CN101233231B - 抗肥胖剂及抗肥胖食品 - Google Patents
抗肥胖剂及抗肥胖食品 Download PDFInfo
- Publication number
- CN101233231B CN101233231B CN2006800273816A CN200680027381A CN101233231B CN 101233231 B CN101233231 B CN 101233231B CN 2006800273816 A CN2006800273816 A CN 2006800273816A CN 200680027381 A CN200680027381 A CN 200680027381A CN 101233231 B CN101233231 B CN 101233231B
- Authority
- CN
- China
- Prior art keywords
- sequence
- milk
- acid bacteria
- present
- obesity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000883 anti-obesity agent Substances 0.000 title claims abstract description 20
- 229940125710 antiobesity agent Drugs 0.000 title claims abstract description 20
- 230000003579 anti-obesity Effects 0.000 title claims description 13
- 235000013305 food Nutrition 0.000 title description 14
- 244000005700 microbiome Species 0.000 claims abstract description 17
- 241000186604 Lactobacillus reuteri Species 0.000 claims abstract description 15
- 208000008589 Obesity Diseases 0.000 claims abstract description 15
- 235000020824 obesity Nutrition 0.000 claims abstract description 15
- 229940001882 lactobacillus reuteri Drugs 0.000 claims description 14
- 241000535433 Lactobacillus reuteri JCM 1112 Species 0.000 claims description 12
- 235000005911 diet Nutrition 0.000 claims description 9
- 230000037213 diet Effects 0.000 claims description 9
- 239000000470 constituent Substances 0.000 claims description 6
- 125000003275 alpha amino acid group Chemical group 0.000 abstract description 66
- 108090001060 Lipase Proteins 0.000 abstract description 25
- 238000012217 deletion Methods 0.000 abstract description 25
- 230000037430 deletion Effects 0.000 abstract description 25
- 102000004882 Lipase Human genes 0.000 abstract description 23
- 239000004367 Lipase Substances 0.000 abstract description 23
- 235000019421 lipase Nutrition 0.000 abstract description 23
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 239000004480 active ingredient Substances 0.000 abstract 1
- 238000007792 addition Methods 0.000 abstract 1
- 125000000539 amino acid group Chemical group 0.000 abstract 1
- 235000012054 meals Nutrition 0.000 abstract 1
- 238000006467 substitution reaction Methods 0.000 abstract 1
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 159
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 116
- 241000894006 Bacteria Species 0.000 description 97
- 235000014655 lactic acid Nutrition 0.000 description 79
- 235000011187 glycerol Nutrition 0.000 description 54
- 239000002773 nucleotide Substances 0.000 description 53
- 125000003729 nucleotide group Chemical group 0.000 description 53
- 108090000623 proteins and genes Proteins 0.000 description 46
- 238000000034 method Methods 0.000 description 26
- 235000001014 amino acid Nutrition 0.000 description 24
- 150000001413 amino acids Chemical class 0.000 description 24
- 238000006073 displacement reaction Methods 0.000 description 24
- 230000000694 effects Effects 0.000 description 19
- 101000925662 Enterobacteria phage PRD1 Endolysin Proteins 0.000 description 14
- 150000002632 lipids Chemical class 0.000 description 14
- 230000004060 metabolic process Effects 0.000 description 12
- 238000009396 hybridization Methods 0.000 description 11
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 description 10
- 102000005369 Aldehyde Dehydrogenase Human genes 0.000 description 10
- 102000005924 Triose-Phosphate Isomerase Human genes 0.000 description 10
- 108700015934 Triose-phosphate isomerases Proteins 0.000 description 10
- 239000002253 acid Substances 0.000 description 10
- 239000007788 liquid Substances 0.000 description 10
- 108010041921 Glycerolphosphate Dehydrogenase Proteins 0.000 description 9
- 102000000587 Glycerolphosphate Dehydrogenase Human genes 0.000 description 9
- 230000000593 degrading effect Effects 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 102100025591 Glycerate kinase Human genes 0.000 description 8
- 238000010353 genetic engineering Methods 0.000 description 8
- 108010086476 glycerate kinase Proteins 0.000 description 8
- 102000057621 Glycerol kinases Human genes 0.000 description 7
- 108700016170 Glycerol kinases Proteins 0.000 description 7
- 230000009471 action Effects 0.000 description 7
- 230000037396 body weight Effects 0.000 description 7
- 239000004310 lactic acid Substances 0.000 description 7
- FRXSZNDVFUDTIR-UHFFFAOYSA-N 6-methoxy-1,2,3,4-tetrahydroquinoline Chemical compound N1CCCC2=CC(OC)=CC=C21 FRXSZNDVFUDTIR-UHFFFAOYSA-N 0.000 description 6
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- 210000004347 intestinal mucosa Anatomy 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 108010078791 Carrier Proteins Proteins 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 235000015097 nutrients Nutrition 0.000 description 5
- 230000002265 prevention Effects 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 4
- 238000013016 damping Methods 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 230000036541 health Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000006228 supernatant Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 241000186660 Lactobacillus Species 0.000 description 3
- 108091000080 Phosphotransferase Proteins 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 230000003321 amplification Effects 0.000 description 3
- 238000010171 animal model Methods 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 102000020233 phosphotransferase Human genes 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001603 reducing effect Effects 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 206010060891 General symptom Diseases 0.000 description 2
- 108010025885 Glycerol dehydratase Proteins 0.000 description 2
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 235000015140 cultured milk Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000021552 granulated sugar Nutrition 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 235000021590 normal diet Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 235000021262 sour milk Nutrition 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- AKXKFZDCRYJKTF-UHFFFAOYSA-N 3-Hydroxypropionaldehyde Chemical compound OCCC=O AKXKFZDCRYJKTF-UHFFFAOYSA-N 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- 241000725101 Clea Species 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- 241000917009 Lactobacillus rhamnosus GG Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 108700005443 Microbial Genes Proteins 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 108010064696 N,O-diacetylmuramidase Proteins 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 238000002869 basic local alignment search tool Methods 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000001925 catabolic effect Effects 0.000 description 1
- BKHZIBWEHPHYAI-UHFFFAOYSA-N chloroform;3-methylbutan-1-ol Chemical compound ClC(Cl)Cl.CC(C)CCO BKHZIBWEHPHYAI-UHFFFAOYSA-N 0.000 description 1
- ZYWFEOZQIUMEGL-UHFFFAOYSA-N chloroform;3-methylbutan-1-ol;phenol Chemical compound ClC(Cl)Cl.CC(C)CCO.OC1=CC=CC=C1 ZYWFEOZQIUMEGL-UHFFFAOYSA-N 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000012252 genetic analysis Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 235000019626 lipase activity Nutrition 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- LCCNCVORNKJIRZ-UHFFFAOYSA-N parathion Chemical compound CCOP(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 LCCNCVORNKJIRZ-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- 238000004062 sedimentation Methods 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000002864 sequence alignment Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 description 1
- 229940038773 trisodium citrate Drugs 0.000 description 1
- 230000037221 weight management Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C12N9/18—Carboxylic ester hydrolases (3.1.1)
- C12N9/20—Triglyceride splitting, e.g. by means of lipase
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/335—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Lactobacillus (G)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0008—Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/90—Isomerases (5.)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/173—Reuteri
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/225—Lactobacillus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biophysics (AREA)
- Polymers & Plastics (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Child & Adolescent Psychology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (2)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP215895/2005 | 2005-07-26 | ||
JP2005215895 | 2005-07-26 | ||
PCT/JP2006/314640 WO2007013438A1 (ja) | 2005-07-26 | 2006-07-25 | 抗肥満剤および抗肥満食品 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201110150966XA Division CN102225078B (zh) | 2005-07-26 | 2006-07-25 | 抗肥胖剂及抗肥胖食品 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101233231A CN101233231A (zh) | 2008-07-30 |
CN101233231B true CN101233231B (zh) | 2011-06-29 |
Family
ID=37683334
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006800273816A Expired - Fee Related CN101233231B (zh) | 2005-07-26 | 2006-07-25 | 抗肥胖剂及抗肥胖食品 |
CN2006800527329A Expired - Fee Related CN101370729B (zh) | 2005-07-26 | 2006-07-25 | 乘客输送机 |
CN201110150966XA Active CN102225078B (zh) | 2005-07-26 | 2006-07-25 | 抗肥胖剂及抗肥胖食品 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2006800527329A Expired - Fee Related CN101370729B (zh) | 2005-07-26 | 2006-07-25 | 乘客输送机 |
CN201110150966XA Active CN102225078B (zh) | 2005-07-26 | 2006-07-25 | 抗肥胖剂及抗肥胖食品 |
Country Status (9)
Country | Link |
---|---|
US (3) | US20100216212A1 (zh) |
EP (2) | EP1918373B1 (zh) |
JP (2) | JP5144263B2 (zh) |
KR (3) | KR20110095929A (zh) |
CN (3) | CN101233231B (zh) |
ES (1) | ES2532481T3 (zh) |
PL (1) | PL2604689T3 (zh) |
PT (1) | PT2604689E (zh) |
WO (1) | WO2007013438A1 (zh) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5679576B2 (ja) * | 2011-06-06 | 2015-03-04 | 東芝エレベータ株式会社 | 乗客コンベア |
KR101394348B1 (ko) * | 2011-10-28 | 2014-05-13 | 대상에프앤에프 주식회사 | 대사질환 또는 염증질환 치료 및 예방 효과가 있는 락토바실러스 플란타륨 dsr920 및 이의 용도 |
CN102583145A (zh) * | 2012-01-19 | 2012-07-18 | 快速电梯有限公司 | 机械式踏板遗失检测装置及具有该检测装置的自动人行道 |
PL3456334T3 (pl) | 2012-06-04 | 2021-05-04 | Biogaia Ab | Bakterie kwasu mlekowego do stosowania dla zapobiegania ubytkowi masy kostnej u ssaków |
WO2014071633A1 (en) | 2012-11-12 | 2014-05-15 | Companie Gervais Danone | Use of lactobacillus rhamnosus strain for reducing weight gain and/or insulin resistance |
EP2925333A1 (en) | 2012-11-12 | 2015-10-07 | Compagnie Gervais Danone | Lactobacillus rhamnosus strain for reducing body fat accumulation |
MY183171A (en) | 2013-04-17 | 2021-02-18 | Suntory Holdings Ltd | Composition containing bacterium belonging to genus lactobacillus |
US20160115559A1 (en) | 2013-04-17 | 2016-04-28 | Suntory Holdings Limited | Bacterium belonging to genus lactobacillus |
WO2015065796A1 (en) | 2013-10-31 | 2015-05-07 | E. I. Du Pont De Nemours And Company | Aqueous ink-jet inks containing two or more binders |
KR102125548B1 (ko) | 2015-02-10 | 2020-06-24 | 주식회사 지니스 | 비만 억제능을 갖는 균주 및 이를 함유하는 약학 조성물 |
EP3423093A4 (en) | 2016-03-04 | 2019-11-13 | The Regents of The University of California | MICROBIAL CONSORTIUM AND USES THEREOF |
WO2018020633A1 (ja) * | 2016-07-28 | 2018-02-01 | 三菱電機株式会社 | 乗客コンベアの走行異常検出装置および乗客コンベアの走行異常検出方法 |
US10653728B2 (en) | 2016-10-17 | 2020-05-19 | New York University | Probiotic compositions for improving metabolism and immunity |
JP6400812B1 (ja) * | 2017-09-06 | 2018-10-03 | 東芝エレベータ株式会社 | 乗客コンベアの異常検出システム |
WO2019168990A1 (en) * | 2018-02-27 | 2019-09-06 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Probiotics and probiotic compositions for regulating body weight |
CN113038957A (zh) | 2018-04-10 | 2021-06-25 | 谢尔塔治疗公司 | 微生物群 |
EP3599212B1 (en) | 2018-07-27 | 2024-06-12 | Otis Elevator Company | Drive misalignment monitoring in a people conveyor |
BR112021002996A2 (pt) * | 2018-08-22 | 2021-05-11 | Dsm Ip Assets B.V. | sacarose isomerases como suplementos alimentícios e nutricionais |
US20210386799A1 (en) * | 2018-09-25 | 2021-12-16 | Duke University | Methods and compositions to treat and prevent infection |
KR102128289B1 (ko) | 2019-08-23 | 2020-06-30 | 주식회사 엔테로바이옴 | 아커만시아 뮤시니필라 eb-amdk27 균주 및 그의 용도 |
CA3153884A1 (en) | 2019-10-07 | 2021-04-15 | Nikole KIMES | Therapeutic pharmaceutical compositions |
CN111254090B (zh) * | 2019-12-30 | 2021-11-05 | 杭州娃哈哈科技有限公司 | 一株具有减肥功能的罗伊氏乳杆菌及其应用 |
CN114344344B (zh) * | 2022-01-05 | 2023-06-13 | 东北农业大学 | 罗伊氏乳杆菌在缓解高脂饮食诱导小鼠肥胖功能中的应用及含有罗伊氏乳杆菌的复合物 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4839281A (en) * | 1985-04-17 | 1989-06-13 | New England Medical Center Hospitals, Inc. | Lactobacillus strains and methods of selection |
ATE323421T1 (de) * | 1997-07-05 | 2006-05-15 | Nestle Sa | Gefrorenes dessert, welches milchsäurebakterien und fermentierbare ballaststoffe enthält |
WO2000064854A1 (fr) | 1999-04-27 | 2000-11-02 | Kabushiki Kaisha Yakult Honsha | Esters d'acides gras conjugues |
US6641808B1 (en) * | 1999-09-22 | 2003-11-04 | Lacpro Industries, Llc | Composition for treatment of obesity |
JP2001120288A (ja) * | 1999-10-29 | 2001-05-08 | Yakult Honsha Co Ltd | 共役脂肪酸グリセリド含有脂質の製造法及び組成物 |
JP4580542B2 (ja) * | 2000-05-17 | 2010-11-17 | 株式會社バイオニア | 肥満又は糖尿病治療用微生物及びその微生物を含む医薬組成物 |
JP4157674B2 (ja) * | 2000-08-14 | 2008-10-01 | 株式会社ヤクルト本社 | 共役脂肪酸含有発酵食品及びその製造法 |
FI109602B (fi) | 2001-01-25 | 2002-09-13 | Valio Oy | Probioottiyhdistelmä |
US20050100531A1 (en) | 2002-06-13 | 2005-05-12 | John Bienenstock | Probiotic therapies |
WO2003105893A2 (en) * | 2002-06-13 | 2003-12-24 | Alimentary Health Limited | Probiotic therapies |
US6942857B2 (en) * | 2002-08-09 | 2005-09-13 | Bioneer Corporation | Microorganisms for preventing and/or treating obesity or diabetes mellitus |
KR100794701B1 (ko) * | 2002-08-09 | 2008-01-14 | (주)바이오니아 | 비만 또는 당뇨 예방 및 치료용 미생물 |
KR100794702B1 (ko) * | 2003-07-21 | 2008-01-14 | (주)바이오니아 | 비만증 또는 당뇨병 예방 및/또는 치료용 미생물 |
JP2003081855A (ja) * | 2002-08-19 | 2003-03-19 | Yakult Honsha Co Ltd | 脂質代謝改善剤およびそれを含有する食品 |
KR20040027180A (ko) | 2002-09-27 | 2004-04-01 | (주)바이오니아 | 비만 또는 당뇨병의 예방 및 치료 효과를 갖는 유산균발효 유제품 및 그 제조방법 |
KR20040037011A (ko) | 2002-10-26 | 2004-05-04 | (주)바이오니아 | 유산균 함유 식품조성물 및 그 제조방법 |
US20040208863A1 (en) * | 2003-01-30 | 2004-10-21 | James Versalovic | Anti-inflammatory activity from lactic acid bacteria |
US7001756B1 (en) * | 2004-02-19 | 2006-02-21 | Genmont Biotech Inc. | Microorganism strain of GM-020 of Lactobacillus rhamnosus and its use for treating obesity |
JP2005304362A (ja) * | 2004-04-20 | 2005-11-04 | Nippon Shokubai Co Ltd | 1,3−プロパンジオール及び/又は3−ヒドロキシプロピオン酸を製造する方法 |
JP2005278414A (ja) * | 2004-03-26 | 2005-10-13 | Nippon Shokubai Co Ltd | 1,3−プロパンジオール及び3−ヒドロキシプロピオン酸を製造する方法 |
JP2005314038A (ja) * | 2004-04-28 | 2005-11-10 | Hitachi Ltd | 乗客コンベア |
KR100740097B1 (ko) | 2005-10-20 | 2007-07-16 | 삼성에스디아이 주식회사 | 배터리의 soc 추정 방법 및 이를 이용한 배터리 관리시스템 |
EP1974734A1 (en) * | 2007-03-28 | 2008-10-01 | Nestec S.A. | Probiotics for reduction of risk of obesity |
JP5077157B2 (ja) * | 2008-08-04 | 2012-11-21 | 高梨乳業株式会社 | 機能性飲食品 |
FI123157B (fi) * | 2009-05-12 | 2012-11-30 | Valio Oy | Probioottien uusi käyttö |
-
2006
- 2006-07-25 CN CN2006800273816A patent/CN101233231B/zh not_active Expired - Fee Related
- 2006-07-25 KR KR1020117015610A patent/KR20110095929A/ko not_active Application Discontinuation
- 2006-07-25 ES ES12189236.8T patent/ES2532481T3/es active Active
- 2006-07-25 CN CN2006800527329A patent/CN101370729B/zh not_active Expired - Fee Related
- 2006-07-25 EP EP06781552.2A patent/EP1918373B1/en not_active Not-in-force
- 2006-07-25 KR KR1020147004764A patent/KR20140043145A/ko not_active Application Discontinuation
- 2006-07-25 CN CN201110150966XA patent/CN102225078B/zh active Active
- 2006-07-25 EP EP12189236.8A patent/EP2604689B1/en active Active
- 2006-07-25 WO PCT/JP2006/314640 patent/WO2007013438A1/ja active Application Filing
- 2006-07-25 JP JP2007528471A patent/JP5144263B2/ja not_active Expired - Fee Related
- 2006-07-25 US US11/997,034 patent/US20100216212A1/en not_active Abandoned
- 2006-07-25 PL PL12189236T patent/PL2604689T3/pl unknown
- 2006-07-25 PT PT12189236T patent/PT2604689E/pt unknown
- 2006-07-25 KR KR1020087003891A patent/KR101411144B1/ko not_active IP Right Cessation
-
2011
- 2011-05-23 JP JP2011114716A patent/JP2011206057A/ja active Pending
- 2011-06-01 US US13/150,558 patent/US8637000B2/en active Active
- 2011-06-06 US US13/154,185 patent/US8637001B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP1918373B1 (en) | 2014-08-20 |
US20120027736A1 (en) | 2012-02-02 |
CN102225078B (zh) | 2012-12-26 |
KR20080034474A (ko) | 2008-04-21 |
PL2604689T3 (pl) | 2015-08-31 |
CN102225078A (zh) | 2011-10-26 |
CN101233231A (zh) | 2008-07-30 |
US20110311501A1 (en) | 2011-12-22 |
KR20140043145A (ko) | 2014-04-08 |
JPWO2007013438A1 (ja) | 2009-02-05 |
KR20110095929A (ko) | 2011-08-25 |
PT2604689E (pt) | 2015-03-09 |
EP1918373A4 (en) | 2009-02-25 |
JP2011206057A (ja) | 2011-10-20 |
US8637000B2 (en) | 2014-01-28 |
CN101370729A (zh) | 2009-02-18 |
ES2532481T3 (es) | 2015-03-27 |
WO2007013438A1 (ja) | 2007-02-01 |
JP5144263B2 (ja) | 2013-02-13 |
EP2604689B1 (en) | 2015-01-21 |
CN101370729B (zh) | 2012-08-29 |
KR101411144B1 (ko) | 2014-06-26 |
US8637001B2 (en) | 2014-01-28 |
EP1918373A1 (en) | 2008-05-07 |
EP2604689A1 (en) | 2013-06-19 |
US20100216212A1 (en) | 2010-08-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101233231B (zh) | 抗肥胖剂及抗肥胖食品 | |
US8697052B2 (en) | Method for alleviating intestinal problems and novel bacterial strains therefor | |
JP4602351B2 (ja) | イヌ科動物プロバイオティク・ビフィドバクテリア・シュードロンガム | |
CN100350919C (zh) | 用于预防或治疗尿草酸盐过多的膳食或药物组合物 | |
CN109475169A (zh) | 促进哺乳动物免疫***成熟的方法 | |
WO2008016214A1 (en) | Lactic acid bacteria isolated from mother's milk with probiotic activity and inhibitory activity against body weight augmentation | |
CN104413334A (zh) | 可食用组合物及其制备方法和用途 | |
CN1867258A (zh) | 一种稳定的液体益生组合物、其制备和应用 | |
US20200078414A1 (en) | Method of preventing or treating obesity using a novel strain of parabacteroides goldsteinii | |
CN103917639A (zh) | 经修饰的***及其用途 | |
JP2010161944A (ja) | 新型カゼイ菌の亜種(sg96)及びこれを含有する菌抑制組成物及びその用途 | |
CN116814501B (zh) | 一种缓解肥胖的长双歧杆菌长亚种及其应用 | |
CN101511377B (zh) | 降低血清甘油三酯剂 | |
US7718171B2 (en) | Reducing heart rate in mammals using milk derived fermentation products produced using Lactobacillus helveticus | |
Wang et al. | Preventive effects of Chinese Xinjiang naturally fermented yogurt separated from Lactobacillus rhamnosus AFY02 on acute gouty arthritis in mice | |
이준영 | Comparative Genomic Analysis of Probiotic Properties of Host-Adapted Lactobacillus spp. Isolated from Pigs | |
CN1110147A (zh) | 抗***反应组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: NESTEC LTD. Free format text: FORMER OWNER: COLLEGE OF VETERINARY MEDICINE AZABU VETERINARY MEDICINE CORPORATION Effective date: 20100512 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: KANAGAWA PREFECTURE, JAPAN TO: VEVEY, SWITZERLAND |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20100512 Address after: Vevey Applicant after: Nestle Purina Petcare Company Address before: Kanagawa Applicant before: School Corporation, Azabu Veterinary Medicine Educational Institution |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20110629 Termination date: 20170725 |
|
CF01 | Termination of patent right due to non-payment of annual fee |